A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphomaSTRAKA, C; PETTENGELL, R; PIELMEIER, A et al.Annals of oncology. 1994, Vol 5, pp S79-S84, issn 0923-7534, SUP1Conference Paper

Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma : high remission rates and reversion to negative of peripheral blood bcl-2 rearrangementMCLAUGHLIN, P; HAGEMEISTER, F. B; SWAN, F et al.Annals of oncology. 1994, Vol 5, pp 73-77, issn 0923-7534, SUP2Conference Paper

Is Hodgkin's disease an infectious disease?WOLF, J; DIEHL, V.Annals of oncology. 1994, Vol 5, pp S105-S111, issn 0923-7534, SUP1Conference Paper

Proliferation of Reed-Sternberg cells and variants in Hodgkin's diseaseGUPTA, R. K; LISTER, T. A; BODMER, J. G et al.Annals of oncology. 1994, Vol 5, pp S117-S119, issn 0923-7534, SUP1Conference Paper

The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyHAGEMEISTER, F. B; PURUGGANAN, R; PODOLOFF, D. A et al.Annals of oncology. 1994, Vol 5, pp 59-63, issn 0923-7534, SUP2Conference Paper

The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomasJAFFE, E. S; ZARATE-OSORNO, A; KINGMA, D. W et al.Annals of oncology. 1994, Vol 5, pp S7-S11, issn 0923-7534, SUP1Conference Paper

Haemopoietic growth factors and dose intensity in high-grade and intermediate-grade lymphomaPETTENGELL, R; CROWTHER, D.Annals of oncology. 1994, Vol 5, pp 133-141, issn 0923-7534, SUP2Conference Paper

Mantle-cell lymphomaDE WOLF-PEETERS, C; PITTALUGA, S.Annals of oncology. 1994, Vol 5, pp S35-S37, issn 0923-7534, SUP1Conference Paper

Prospects for the therapeutic use of antisense oligonucleotides in malignant lymphomasMAGRATH, I. T.Annals of oncology. 1994, Vol 5, pp S67-S70, issn 0923-7534, SUP1Conference Paper

The treatment of Hodgkin's diseaseROSENBERG, S. A.Annals of oncology. 1994, Vol 5, pp 17-21, issn 0923-7534, SUP2Conference Paper

Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphomaCANELLOS, G. P.Annals of oncology. 1994, Vol 5, pp 121-122, issn 0923-7534, SUP2Conference Paper

Low-grade lymphoma 1993 : state of the artHORNING, S. J.Annals of oncology. 1994, Vol 5, pp 23-27, issn 0923-7534, SUP2Conference Paper

Lymphoma complicating immunodeficiency disordersLEVINE, A. M.Annals of oncology. 1994, Vol 5, pp 29-35, issn 0923-7534, SUP2Conference Paper

Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangementWILLIAMS, M. E; SWERDLOW, S. H.Annals of oncology. 1994, Vol 5, pp S71-S73, issn 0923-7534, SUP1Conference Paper

Lymphokine receptors: a target for immunotherapy of lymphomasWALDMANN, T. A.Annals of oncology. 1994, Vol 5, pp S13-S17, issn 0923-7534, SUP1Conference Paper

Modern treatment of malignant lymphomas : a multidisciplinary approach ? The Kaplan memorial lectureBONADONNA, G.Annals of oncology. 1994, Vol 5, pp 5-16, issn 0923-7534, SUP2Conference Paper

Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entityKADIN, M. E.Annals of oncology. 1994, Vol 5, pp S25-S30, issn 0923-7534, SUP1Conference Paper

Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemicWEISENBURGER, D. D.Annals of oncology. 1994, Vol 5, pp S19-S24, issn 0923-7534, SUP1Conference Paper

Pediatric lymphomas: recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhoodMURPHY, S. B.Annals of oncology. 1994, Vol 5, pp S31-S33, issn 0923-7534, SUP1Conference Paper

Early bone marrow transplantation in Hodgkin's diseaseARMITAGE, J. O.Annals of oncology. 1994, Vol 5, pp 161-163, issn 0923-7534, SUP2Conference Paper

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) TrialCHUGH, Rashmi; WATHEN, J. Kyle; BENJAMIN, Robert S et al.Clinical cancer research (Print). 2010, Vol 16, Num 19, pp 4884-4891, issn 1078-0432, 8 p.Article

Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients : a case-controlled analysis of the EBMT Registry dataLIBERTI, G; PEARCE, R; TAGHIPOUR, G et al.Annals of oncology. 1994, Vol 5, pp 151-153, issn 0923-7534, SUP2Conference Paper

Early-stage Hodgkin's disease : long-term results with radiotherapy alone or combined radiotherapy and chemotherapyBRUSAMOLINO, E; LAZZARINO, M; CORBELLA, F et al.Annals of oncology. 1994, Vol 5, pp 101-106, issn 0923-7534, SUP2Conference Paper

High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma : the EBMT experienceSWEETENHAM, J. W; PROCTOR, S. J; BLAISE, D et al.Annals of oncology. 1994, Vol 5, pp 155-159, issn 0923-7534, SUP2Conference Paper

Hybrid LOPP/EVA is not better than LOPP alternating with EVAP : a prematurely terminated British National Lymphoma Investigation randomized trialHANCOCK, B. W; VAUGHAN HUDSON, G; BAUGHAN HUDSON, B et al.Annals of oncology. 1994, Vol 5, pp 117-120, issn 0923-7534, SUP2Conference Paper